Immunofluorescence analysis of tumor sections and non‐tumor sections (Figure S1) showed that SLAMF7 was mainly localized to the tumor periphery, with lower levels in the tumor core (Figure 1H), implying that SLAMF7 expression may hinder glioma development. The gene discussed is SLAMF7; the disease is neoplasm.